Amgen's AI Strategy Aims to Revolutionize Patient Care

2025-05-28 transformation

Thousand Oaks, Wednesday, 28 May 2025.
Amgen aims to transform patient care with AI, enhancing pharmaceutical innovation and engagement to create resilient healthcare systems prioritizing patient needs and improved treatment outcomes.

Leveraging AI for Patient-Centric Healthcare

Amgen’s innovative use of artificial intelligence (AI) and digital technologies stands at the forefront of transforming patient care and engagement in the pharmaceutical industry. According to Alex Koehler, Amgen’s vice president and head of digital technology and innovation, AI is crucial in personalizing patient interactions, predicting barriers to healthcare access, and streamlining patient journeys. By utilizing data-driven insights, Amgen aims to revolutionize the way patients journey through the healthcare system, thereby improving access to therapies and outcomes [2].

AI and Quantum Computing: A Transformative Synergy

In pursuit of innovation, Amgen is engaging in the integration of quantum computing and AI to vastly accelerate drug discovery processes. This technological synergy can potentially reduce research and development cycles by 50-70%, allowing new drugs to reach patients faster and more cost-effectively [5]. This represent a remarkable shift in the biopharmaceutical landscape, where efficiency and precision in drug development are paramount to meeting patient needs and addressing complex medical challenges.

Strategic Advances in Cardiovascular Health

Amgen’s AI strategy also extends to ambitious healthcare goals, such as its target to halve cardiovascular events in the U.S. by 2030. Cardiovascular disease remains a leading cause of morbidity and mortality, with AI playing an instrumental role in this strategic initiative. The approach involves targeting high levels of LDL cholesterol (LDL-C), a significant risk factor for heart attacks and strokes. This comprehensive plan underscores Amgen’s commitment to leveraging technology to save lives on a large scale [3][7].

Enhancing Global Pharmaceutical Ecosystems

As part of its global strategy to enhance healthcare delivery, Amgen has recently established a Technology and Innovation Centre in Hyderabad, supported by a $200 million investment. This center is poised to become a hub for addressing key challenges in pharmaceutical innovation and patient care, fostering collaboration, and generating data-driven insights to further refine healthcare solutions [9]. This initiative aligns with a broader trend among pharmaceutical companies to build robust, tech-driven capabilities that enhance operational resilience and patient outcomes.

Bronnen

healthcare transformation AI strategy